FULGENT GENETICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
FULGENT GENETICS, INC. (FLGT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 324.00 thousand shares for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-17.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2017-03-17
- FULGENT GENETICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2016-12-31 was 0.00 shares.
- FULGENT GENETICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 324.00K shares, a 18.25% increase from fiscal 2015.
- FULGENT GENETICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 274.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | 324.00K shares 10-K · filed 2017-03-17 | |
| 2016-09-30 | 324.00K shares 10-Q · filed 2016-11-14 | ||
| 2015-12-31 | 274.00K shares 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |